GERN FY 2018 Earnings — Geron Corporation Revenue & Financial Results | Market Cap Arena

GERNGeron Corporation

$1B

FY 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$1M+0.1% YoY

Gross Profit

-$12M-1093.5% margin

Operating Income

-$31M-2914.9% margin

Net Income

-$27M-2534.4% margin

EPS (Diluted)

$-0.15

Cash Flow

Operating Cash Flow

-$21M

Free Cash Flow

-$21M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$185M

Total Liabilities

$8M

Stockholders' Equity

$178M

Cash & Equivalents

$11M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1M	$1M	+0.1%
Gross Profit	-$12M	-$7M	-58.1%
Operating Income	-$31M	-$29M	-6.2%
Net Income	-$27M	-$28M	+3.2%